Dissecting EBV-specific T-cell responses after allogeneic EBV-specific T-cell transfer for CNS PTLD

被引:0
|
作者
Maecker-Kolhoff, Britta [1 ,2 ]
Schultze-Florey, Rebecca E. [1 ,2 ]
Tischer, Sabine [2 ,3 ]
Kuhlmann, Leonie [4 ]
Hundsdoerfer, Patrick [5 ,6 ]
Koch, Arend [5 ,7 ]
Ravens, Sarina [4 ]
Goudeva, Lilia [3 ]
Schultze-Florey, Christian [4 ,8 ]
Koenecke, Christian [4 ,8 ]
Blasczyk, Rainer [3 ]
Koehl, Ulrike [2 ,9 ]
Heuft, Hans-Gert [3 ]
Prinz, Immo [4 ]
Eiz-Vesper, Britta [2 ,3 ]
机构
[1] Hannover Med Sch, Pediat Hematol & Oncol, Hannover, Germany
[2] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany
[3] Hannover Med Sch, Inst Transfus Med, Hannover, Germany
[4] Hannover Med Sch, Inst Immunol, Hannover, Germany
[5] Free Univ Berlin, Charite Univ Med Berlin, Berlin, Germany
[6] Berlin Inst Hlth, Dept Pediat Hematol & Oncol, Berlin, Germany
[7] Berlin Inst Hlth, Dept Neuropathol, Berlin, Germany
[8] Hannover Med Sch, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Hannover, Germany
[9] Hannover Med Sch, Inst Cellular Therapeut, Hannover, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
67
引用
收藏
页码:46 / 46
页数:1
相关论文
共 50 条
  • [21] IMMUNE REGULATION OF EPSTEIN-BARR-VIRUS (EBV) - EBV NUCLEAR ANTIGEN AS A TARGET FOR EBV-SPECIFIC T-CELL LYSIS
    MOSS, DJ
    MISKO, IS
    SCULLEY, TB
    APOLLONI, A
    KHANNA, R
    BURROWS, SR
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1991, 13 (02): : 147 - 156
  • [22] Effectiveness and safety outcomes in patients with EBV plus PTLD treated with allogeneic EBV-specific T-cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe
    Trappe, Ralf Ulrich
    Choquet, Sylvain
    Clark, Andrew
    Renard, Cecile
    Chaganti, Sridhar
    Comoli, Patrizia
    Duan, Xinyuan
    Xing, Baodong
    Wu, Charley
    Gamelin, Laurence
    Terwey, Jan-Henrik
    Friedetzky, Anke
    Dierickx, Daan
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 148 - 148
  • [23] Comprehensive Activation Profiling of the Tabelecleucel Library, an Off-the-Shelf, Allogeneic EBV-Specific T-Cell Therapy
    Benoun, Joseph M.
    Ruiz, Fiona J.
    Widmann, Kate
    Jehng, Tiffany
    Spindler, Tassja
    Abraham, Jay
    Minne, Sumer
    Tracy, Karen E.
    Munson, Daniel
    Thota, Vinith
    Wang, Arthur
    Chuan, Johnathan
    Yedwabnick, Matt
    Dubovsky, Jason A.
    BLOOD, 2021, 138
  • [24] Impact of γ-chain cytokines on EBV-specific T cell cultures
    Anna Merlo
    Riccardo Turrini
    Cristina Trento
    Paola Zanovello
    Riccardo Dolcetti
    Antonio Rosato
    Journal of Translational Medicine, 8
  • [25] Impact of γ-chain cytokines on EBV-specific T cell cultures
    Merlo, Anna
    Turrini, Riccardo
    Trento, Cristina
    Zanovello, Paola
    Dolcetti, Riccardo
    Rosato, Antonio
    JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [26] Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome
    Loebel, Madlen
    Strohschein, Kristin
    Giannini, Carolin
    Koelsch, Uwe
    Bauer, Sandra
    Doebis, Cornelia
    Thomas, Sybill
    Unterwalder, Nadine
    von Baehr, Volker
    Reinke, Petra
    Knops, Michael
    Hanitsch, Leif G.
    Meisel, Christian
    Volk, Hans-Dieter
    Scheibenbogen, Carmen
    PLOS ONE, 2014, 9 (01):
  • [27] Effectiveness and safety outcomes in patients with EBV+ PTLD treated with allogeneic EBV-specific T-cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe.
    Choquet, Sylvain
    Clark, Andrew
    Renard, Cecile
    Uttenthal, Ben
    Chaganti, Sridhar
    Trappe, Ralf Ulrich
    Comoli, Patrizia
    Duan, Xinyuan
    Xing, Baodong
    Wu, Charley
    Gamelin, Laurence
    Terwey, Jan-Henrik
    Friedetzky, Anke
    Dierickx, Daan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] EBV-SPECIFIC T-CELL (EBVTc) ACTIVITY IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS (TX PTS) WITH AND WITHOUT EBV VIREMIA
    Puliyanda, Dechu P.
    Ge, Shili
    Karasyov, Artur
    Petroysan, Anna
    Jordan, Stanley C.
    Kamil, Elaine S.
    Toyoda, Mieko
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 94 - 94
  • [29] Resolution of EBV+ CNS lymphoma with appearance of CSF EBV-specific T cells
    de Beukelaar, JW
    van Arkel, C
    van den Bent, MJ
    Van't Veer, MB
    van Doornum, GJ
    Cornelissen, JJ
    Smitt, PAS
    Gratama, JW
    ANNALS OF NEUROLOGY, 2005, 58 (05) : 788 - 792
  • [30] Functionally impaired GPI-anchor negative EBV-specific T cells after Alemtuzumab mediated T-cell depletion
    Kouka, A.
    Goetze, C.
    Schaefer, L.
    Theobald, M.
    Herr, W.
    Meyer, R. G.
    Wagner, E. M.
    ONKOLOGIE, 2012, 35 : 92 - 92